Eswatini News

“WHY SHORTER TB REGIMEN IS THE MOST PREFFERED BY PATIENTS IN ESWATINI”

Siphephelosethu Ntjangase is a 21-year-old university student from Hluti village in the Shiselweni region who suffers from pulmonary drug resistant tuberculosis (DR-TB).  In October 2021 before getting checked, he noticed that he was losing weight, sweating at night and had a persistent cough that had lasted over a year. From the first test, the diagnosis was not conclusive which forced him to opt for a second opinion and that is when he tested positive for tuberculosis (TB).

BUILDING CORE CAPACITIES FOR POINTS OF ENTRY THROUGH MULTISECTORAL COLLABORATION AND...

As the COVID-19 pandemic enters the third year, there is a need for building resilient border health systems to curb the international spread of diseases. The Joint External Evaluation (JEE) of the implementation of the International Health Regulations (IHR) 2005 which was conducted in 2018 across 19 technical areas revealed limited capacity and major gaps under the Points of Entry. This poses a great risk of the international spread of diseases between Eswatini and neighbouring South Africa and Mozambique as well as other countries in Southern Africa.

Giving 110%: Eswatini’s early rollout of COVID-19 vaccines 

“I didn’t think that I could get COVID out here in my village,” says Linda Simelane at her home in Sibebe in rural Eswatini.

“I stay away from people, I stay alone, but it happened that I started getting flu symptoms.” 

At the peak of Africa’s first wave of infections in mid-2020, Ms Simelane’s son took her to get tested for COVID-19, but as she waited for her results at home, her condition rapidly deteriorated.

Access to Affordable Vaccines for Middle Income Countries Workshop kicks off in Eswa...

The Minister of Health, Honourable Lizzie Nkosi opened the second consultative workshop for improving access to affordable vaccines for Middle Income Countries (MICs) in Africa, at the Royal Swazi Convention Centre in Ezulwini on 30 October 2019. This meeting, organised by the World Health Organization (WHO) Regional Office for Africa is attended by stakeholders involved in the procurement and use of vaccines from seven Middle Income  Countries in  African.